modafinil has been researched along with Overweight in 1 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Modafinil was reported to be effective for treating sleepiness, venlafaxine for cataplexy, and sodium oxybate for all symptoms, across all puberty groups." | 1.36 | Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. ( Aran, A; Einen, M; Lin, L; Mignot, E; Nishino, S; Plazzi, G, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aran, A | 1 |
| Einen, M | 1 |
| Lin, L | 1 |
| Plazzi, G | 1 |
| Nishino, S | 1 |
| Mignot, E | 1 |
1 other study available for modafinil and Overweight
| Article | Year |
|---|---|
Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.
Topics: Adjuvants, Anesthesia; Adolescent; Age Distribution; Age of Onset; Antidepressive Agents, Second-Gen | 2010 |